Evidence map›Paper›PMID 21789190›Full record

ArticlePloS one2011

Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice.

Marina A Kapina, Galina S Shepelkova, Vadim G Avdeenko, Anna N Guseva, Tatiana K Kondratieva, Vladimir V Evstifeev, Alexander S Apt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. The role of IL-11 in chronic diseases.Frontiers in immunology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Interleukin-11 receptor subunit α-1 is required for maximal airway responsiveness to methacholine after acute exposure to ozone.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marina A KapinaDepartment of Immunology, Central Institute for Tuberculosis, Moscow, Russia.
Galina S Shepelkova
Vadim G Avdeenko
Anna N Guseva
Tatiana K Kondratieva
Vladimir V Evstifeev
Alexander S Apt
Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences · RU

Funding

Immunity to and pathogeneses of M. tuberculosis and M. avium infections in miceR01AI078864 · NIAID · CENTRAL INSTITUTE FOR TUBERCULOSIS · PI APT, ALEXANDER S · 2008 to 2011
$322k
NIAID NIH HHS R01 AI078864
6 · The paper itself

Abstract

IL-11 is multifunctional cytokine whose physiological role in the lungs during pulmonary tuberculosis (TB) is poorly understood. Here, using in vivo administration of specific antibodies against IL-11, we demonstrate for the first time that blocking IL-11 diminishes histopathology and neutrophilic infiltration of the lung tissue in TB-infected genetically susceptible mice. Antibody treatment decreased the pulmonary levels of IL-11 and other key inflammatory cytokines not belonging to the Th1 axis, and down-regulated IL-11 mRNA expression. This suggests the existence of a positive feedback loop at the transcriptional level, which is further supported by up-regulation of IL-11 mRNA expression in the presence of rIL-11 in in vitro cultures of lung cells. These findings imply a pathogenic role for IL-11 during the early phase of Mycobacterium tuberculosis-triggered disease in a genetically susceptible host.

Indexed as

Genetic Predisposition to DiseaseAnimalsAntibodiesAutocrine CommunicationFemaleInterleukin-11LungMiceMycobacterium tuberculosisPneumoniaTranscription, GeneticTuberculosis, PulmonaryAntibodiesInterleukin-11

Identifiers

PMID21789190
PMCPMC3137601
OpenAlexW2068460152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.